Q13084 (RM28_HUMAN) Homo sapiens (Human)

Large ribosomal subunit protein bL28m UniProtKBInterProSTRINGInteractive Modelling

256 aa; Sequence (Fasta)

Available Structures

38 Experimental Structures

DescriptionPDB IDOligo-stateRangeSeq id (%)Ligands
State B of the human mitoribosomal large subunit assembly intermediate Heteromer
L0R8F8; O14561; O75394; P09001; P49406; Q13405; Q14197; Q16540; Q4U2R6; Q5T653; Q6P161; Q6P1L8; Q7Z2W9; Q7Z6M4; Q7Z7F7; Q7Z7H8; Q86TS9; Q8IXM3; Q8N5N7; Q8N983; Q8TAE8; Q8TCC3; Q96A35; Q96CB9; Q96DV4; Q96EH3; Q96EL3; Q96GC5; Q9BQ48; Q9BQC6; Q9BRJ2; Q9BYC8; Q9BYC9; Q9BYD1; Q9BYD2; Q9BYD3; Q9BZE1; Q9H0U6; Q9H2W6; Q9H9J2; Q9HD33; Q9NP92; Q9NQ50; Q9NRX2; Q9NVS2; Q9NWU5; Q9NX20; Q9NYK5; Q9NZE8; Q9P015; Q9P0J6; Q9P0M9; Q9UI43; Q9Y3B7; Q9Y6G3;
2-245
100PM8;SAM;ZN; 88×MG;K;N;FES;
State A of the human mitoribosomal large subunit assembly intermediate Heteromer
L0R8F8; O14561; O75394; P09001; P49406; Q13405; Q14197; Q16540; Q4U2R6; Q5T653; Q6P161; Q6P1L8; Q7Z2W9; Q7Z6M4; Q7Z7F7; Q7Z7H8; Q86TS9; Q8IXM3; Q8N5N7; Q8N983; Q8TAE8; Q8TCC3; Q96A35; Q96CB9; Q96DV4; Q96EH3; Q96EL3; Q96GC5; Q9BQ48; Q9BQC6; Q9BRJ2; Q9BYC8; Q9BYC9; Q9BYD1; Q9BYD2; Q9BYD3; Q9BZE1; Q9H0U6; Q9H2W6; Q9H9J2; Q9HD33; Q9NP92; Q9NQ50; Q9NRX2; Q9NVS2; Q9NWU5; Q9NX20; Q9NYK5; Q9NZE8; Q9P015; Q9P0J6; Q9P0M9; Q9Y3B7; Q9Y6G3;
2-245
100PM8;SAM;ZN; 97×MG;K;FES;
human mitoribosomal large subunit assembly intermediate 1 with GTPBP10-GTPBP7 Heteromer
A4D1E9; L0R8F8; O14561; O75394; P09001; P49406; Q13405; Q14197; Q16540; Q4U2R6; Q5T653; Q6P161; Q6P1L8; Q7Z2W9; Q7Z6M4; Q7Z7F7; Q7Z7H8; Q86TS9; Q8IXM3; Q8N5N7; Q8N983; Q8TAE8; Q8TCC3; Q96A35; Q96CB9; Q96DV4; Q96EH3; Q96EL3; Q96GC5; Q9BQ48; Q9BQC6; Q9BRJ2; Q9BT17; Q9BYC8; Q9BYC9; Q9BYD1; Q9BYD2; Q9BYD3; Q9BZE1; Q9H0U6; Q9H2W6; Q9H9J2; Q9HD33; Q9NP92; Q9NQ50; Q9NRX2; Q9NVS2; Q9NWU5; Q9NX20; Q9NYK5; Q9NZE8; Q9P015; Q9P0M9; Q9Y3B7; Q9Y6G3;
2-245
100ZN;PM8;SAM;GNP; 96×MG; 10×K;
Assembly intermediate of human mitochondrial ribosome large subunit (largely unfolded rRNA with MAL… Heteromer
L0R8F8; O14561; O75394; P09001; P49406; P52815; Q13405; Q14197; Q16540; Q4U2R6; Q5T653; Q6P161; Q6P1L8; Q7Z2W9; Q7Z7F7; Q7Z7H8; Q86TS9; Q8IXM3; Q8N5N7; Q8N983; Q8TAE8; Q8TCC3; Q96A35; Q96DV4; Q96EH3; Q96EL3; Q96GC5; Q9BQ48; Q9BQC6; Q9BRJ2; Q9BYC8; Q9BYC9; Q9BYD1; Q9BYD2; Q9BYD3; Q9BZE1; Q9H0U6; Q9H2W6; Q9H9J2; Q9HD33; Q9NP92; Q9NQ50; Q9NRX2; Q9NVS2; Q9NWU5; Q9NX20; Q9NYK5; Q9NZE8; Q9P015; Q9P0M9; Q9Y3B7; Q9Y6G3;
2-245
10035×MG;K;ZN;FES;8Q1;
Human mitoribosomal large subunit assembly intermediate 2 with GTPBP7 Heteromer
L0R8F8; O14561; O75394; P09001; P49406; Q13405; Q14197; Q16540; Q4U2R6; Q5T653; Q6P161; Q6P1L8; Q7Z2W9; Q7Z6M4; Q7Z7F7; Q7Z7H8; Q86TS9; Q8IXM3; Q8N5N7; Q8N983; Q8TAE8; Q8TCC3; Q96A35; Q96CB9; Q96DV4; Q96EH3; Q96EL3; Q96GC5; Q9BQ48; Q9BQC6; Q9BRJ2; Q9BT17; Q9BYC8; Q9BYC9; Q9BYD1; Q9BYD2; Q9BYD3; Q9BZE1; Q9H0U6; Q9H2W6; Q9H9J2; Q9HD33; Q9NP92; Q9NQ50; Q9NRX2; Q9NVS2; Q9NWU5; Q9NX20; Q9NYK5; Q9NZE8; Q9P015; Q9P0J6; Q9P0M9; Q9Y3B7; Q9Y6G3;
2-245
100ZN; 38×MG;FES;PM8;SAM;GNP;
State C of the human mitoribosomal large subunit assembly intermediate Heteromer
L0R8F8; O14561; O75394; P09001; P49406; Q13405; Q14197; Q16540; Q4U2R6; Q5T653; Q6P161; Q6P1L8; Q7Z2W9; Q7Z6M4; Q7Z7F7; Q7Z7H8; Q86TS9; Q8IXM3; Q8N5N7; Q8N983; Q8TAE8; Q8TCC3; Q96A35; Q96CB9; Q96DV4; Q96EH3; Q96EL3; Q96GC5; Q9BQ48; Q9BQC6; Q9BRJ2; Q9BYC8; Q9BYC9; Q9BYD1; Q9BYD2; Q9BYD3; Q9BZE1; Q9H0U6; Q9H2W6; Q9H4K7; Q9H9J2; Q9HD33; Q9NP92; Q9NQ50; Q9NRX2; Q9NVS2; Q9NWU5; Q9NX20; Q9NYK5; Q9NZE8; Q9P015; Q9P0J6; Q9P0M9; Q9Y3B7; Q9Y6G3;
2-245
100GDP; 95×MG;PM8;SAM;ZN; 10×K;FES;
39S human mitochondrial large ribosomal subunit with mtRF1 and P-site tRNA Heteromer
O75394; O75570; P09001; P49406; P52815; Q13405; Q14197; Q16540; Q4U2R6; Q5T653; Q6P161; Q6P1L8; Q7Z2W9; Q7Z7F7; Q7Z7H8; Q86TS9; Q8IXM3; Q8N5N7; Q8N983; Q8TAE8; Q8TCC3; Q96A35; Q96DV4; Q96EL3; Q96GC5; Q9BQ48; Q9BQC6; Q9BRJ2; Q9BYC8; Q9BYC9; Q9BYD1; Q9BYD2; Q9BYD3; Q9BYD6; Q9BZE1; Q9H0U6; Q9H2W6; Q9H9J2; Q9HD33; Q9NP92; Q9NQ50; Q9NRX2; Q9NVS2; Q9NWU5; Q9NX20; Q9NYK5; Q9NZE8; Q9P015; Q9P0J6; Q9P0M9; Q9Y3B7; Q9Y6G3;
2-245
10034×K; 228×MG;VAL;ZN;FS2;MET;
Structure of a human mitochondrial ribosome large subunit assembly intermediate in complex with MTE… Heteromer
L0R8F8; O14561; O75394; P09001; P49406; Q13405; Q14197; Q16540; Q4U2R6; Q5T653; Q6P1L8; Q7Z2W9; Q7Z6M4; Q7Z7F7; Q7Z7H8; Q86TS9; Q8IXM3; Q8N5N7; Q8N983; Q8TAE8; Q8TCC3; Q96A35; Q96CB9; Q96DV4; Q96EH3; Q96EL3; Q96GC5; Q9BQ48; Q9BQC6; Q9BRJ2; Q9BYC8; Q9BYC9; Q9BYD1; Q9BYD2; Q9BYD3; Q9BZE1; Q9H0U6; Q9H2W6; Q9H4K7; Q9H9J2; Q9HD33; Q9NP92; Q9NQ50; Q9NRX2; Q9NVS2; Q9NWU5; Q9NX20; Q9NYK5; Q9NZE8; Q9P015; Q9P0J6; Q9P0M9; Q9Y3B7; Q9Y6G3;
2-244
100ZN; 70×MG;GTP;
Cryo-EM structure of late human 39S mitoribosome assembly intermediates, state 3C Heteromer
O75394; P09001; P49406; Q13405; Q14197; Q16540; Q4U2R6; Q5T653; Q6P161; Q6P1L8; Q7Z2W9; Q7Z7F7; Q7Z7H8; Q86TS9; Q8IXM3; Q8N5N7; Q8N983; Q8TAE8; Q8TCC3; Q96A35; Q96DV4; Q96EL3; Q96GC5; Q9BQ48; Q9BQC6; Q9BRJ2; Q9BYC8; Q9BYC9; Q9BYD1; Q9BYD2; Q9BYD3; Q9BZE1; Q9H0U6; Q9H2W6; Q9H9J2; Q9HD33; Q9NP92; Q9NQ50; Q9NRX2; Q9NVS2; Q9NWU5; Q9NX20; Q9NYK5; Q9NZE8; Q9P015; Q9P0M9; Q9Y3B7; Q9Y6G3;
2-244
10049×MG;ZN;
Structure of mature human mitochondrial ribosome large subunit in complex with GTPBP6 (PTC conforma… Heteromer
O43824; O75394; P09001; P49406; Q13405; Q14197; Q16540; Q4U2R6; Q5T653; Q6P161; Q6P1L8; Q7Z2W9; Q7Z7F7; Q7Z7H8; Q86TS9; Q8IXM3; Q8N5N7; Q8N983; Q8TAE8; Q8TCC3; Q96A35; Q96DV4; Q96EL3; Q96GC5; Q9BQ48; Q9BQC6; Q9BRJ2; Q9BYC8; Q9BYC9; Q9BYD1; Q9BYD2; Q9BYD3; Q9BZE1; Q9H0U6; Q9H2W6; Q9H9J2; Q9HD33; Q9NP92; Q9NQ50; Q9NRX2; Q9NVS2; Q9NWU5; Q9NX20; Q9NYK5; Q9NZE8; Q9P015; Q9P0J6; Q9P0M9; Q9Y3B7; Q9Y6G3;
2-244
100ZN; 88×MG;GTP;
Cryo-EM structure of late human 39S mitoribosome assembly intermediates, state 1 Heteromer
A4D1E9; L0R8F8; O14561; P09001; P49406; Q13405; Q14197; Q16540; Q4U2R6; Q5T653; Q6P161; Q6P1L8; Q7Z2W9; Q7Z7H8; Q86TS9; Q8IXM3; Q8N5N7; Q8N983; Q8TAE8; Q8TCC3; Q96A35; Q96DV4; Q96EH3; Q96EL3; Q9BQ48; Q9BQC6; Q9BRJ2; Q9BYC8; Q9BYC9; Q9BYD1; Q9BYD2; Q9BYD3; Q9BZE1; Q9H0U6; Q9H9J2; Q9HC36; Q9HD33; Q9NP92; Q9NRX2; Q9NUL7; Q9NVS2; Q9NWU5; Q9NX20; Q9NYK5; Q9P015; Q9P0M9; Q9Y3B7; Q9Y6G3;
2-244
10048×MG;ZN;PNS;
Cryo-EM structure of the human mtLSU assembly intermediate upon MRM2 depletion - class 1 Heteromer
L0R8F8; O14561; O75394; P09001; P49406; Q13405; Q14197; Q16540; Q4U2R6; Q5T653; Q6P1L8; Q7Z2W9; Q86TS9; Q8IXM3; Q8N5N7; Q8N983; Q8TAE8; Q8TCC3; Q96A35; Q96DV4; Q96EH3; Q9BQ48; Q9BQC6; Q9BRJ2; Q9BYC8; Q9BYC9; Q9BYD1; Q9BYD2; Q9BYD3; Q9BZE1; Q9H0U6; Q9H9J2; Q9HD33; Q9NP92; Q9NRX2; Q9NVS2; Q9NWU5; Q9NX20; Q9NYK5; Q9NZE8; Q9P015; Q9P0M9; Q9Y6G3;
2-244
100ZN;
Cryo-EM structure of late human 39S mitoribosome assembly intermediates, state 3D Heteromer
O75394; P09001; P49406; Q13405; Q14197; Q16540; Q4U2R6; Q5T653; Q6P161; Q6P1L8; Q7Z2W9; Q7Z7F7; Q7Z7H8; Q86TS9; Q8IXM3; Q8N5N7; Q8N983; Q8TAE8; Q8TCC3; Q96A35; Q96DV4; Q96EL3; Q96GC5; Q9BQ48; Q9BQC6; Q9BRJ2; Q9BYC8; Q9BYC9; Q9BYD1; Q9BYD2; Q9BYD3; Q9BZE1; Q9H0U6; Q9H2W6; Q9H9J2; Q9HD33; Q9NP92; Q9NQ50; Q9NRX2; Q9NVS2; Q9NWU5; Q9NX20; Q9NYK5; Q9NZE8; Q9P015; Q9P0M9; Q9Y3B7; Q9Y6G3;
2-244
10049×MG;ZN;
Structure of a native assembly intermediate of the human mitochondrial ribosome with unfolded inter… Heteromer
L0R8F8; O14561; O75394; P09001; P49406; Q13405; Q14197; Q16540; Q4U2R6; Q5T653; Q6P161; Q6P1L8; Q7Z2W9; Q7Z7F7; Q7Z7H8; Q86TS9; Q8IXM3; Q8N5N7; Q8N983; Q8TAE8; Q8TCC3; Q96A35; Q96DV4; Q96EH3; Q96EL3; Q96GC5; Q9BQ48; Q9BQC6; Q9BRJ2; Q9BYC8; Q9BYC9; Q9BYD1; Q9BYD2; Q9BYD3; Q9BZE1; Q9H0U6; Q9H2W6; Q9H9J2; Q9HD33; Q9NP92; Q9NQ50; Q9NRX2; Q9NVS2; Q9NWU5; Q9NX20; Q9NYK5; Q9NZE8; Q9P015; Q9P0M9; Q9Y3B7; Q9Y6G3;
2-244
10049×MG;ZN;PNS;
Structure of a human mitochondrial ribosome large subunit assembly intermediate in complex with MTE… Heteromer
L0R8F8; O14561; O75394; P09001; P49406; Q13405; Q14197; Q16540; Q4U2R6; Q5T653; Q6P1L8; Q7Z2W9; Q7Z6M4; Q7Z7F7; Q7Z7H8; Q86TS9; Q8IXM3; Q8N5N7; Q8N983; Q8TAE8; Q8TCC3; Q96A35; Q96CB9; Q96DV4; Q96EH3; Q96EL3; Q96GC5; Q9BQ48; Q9BQC6; Q9BRJ2; Q9BYC8; Q9BYC9; Q9BYD1; Q9BYD2; Q9BYD3; Q9BZE1; Q9H0U6; Q9H2W6; Q9H9J2; Q9HD33; Q9NP92; Q9NQ50; Q9NRX2; Q9NVS2; Q9NWU5; Q9NX20; Q9NYK5; Q9NZE8; Q9P015; Q9P0J6; Q9P0M9; Q9Y3B7; Q9Y6G3;
2-244
100ZN; 61×MG;
Cryo-EM structure of the human mtLSU assembly intermediate upon MRM2 depletion - class 4 Heteromer
L0R8F8; O14561; O75394; P09001; P49406; Q13405; Q14197; Q16540; Q4U2R6; Q5T653; Q6P1L8; Q7Z2W9; Q7Z7H8; Q86TS9; Q8IXM3; Q8N5N7; Q8N983; Q8TAE8; Q8TCC3; Q96A35; Q96DV4; Q96EH3; Q96GC5; Q9BQ48; Q9BQC6; Q9BRJ2; Q9BYC8; Q9BYC9; Q9BYD1; Q9BYD2; Q9BYD3; Q9BZE1; Q9H0U6; Q9H9J2; Q9HD33; Q9NP92; Q9NRX2; Q9NVS2; Q9NWU5; Q9NX20; Q9NYK5; Q9NZE8; Q9P015; Q9P0J6; Q9P0M9; Q9Y6G3;
2-244
10050×MG;ZN;
Structure of a human mitochondrial ribosome large subunit assembly intermediate in complex with MTE… Heteromer
L0R8F8; O14561; O75394; P09001; P49406; Q13405; Q14197; Q16540; Q4U2R6; Q5T653; Q6P1L8; Q7Z2W9; Q7Z6M4; Q7Z7F7; Q7Z7H8; Q86TS9; Q8IXM3; Q8N5N7; Q8N983; Q8TAE8; Q8TCC3; Q96A35; Q96CB9; Q96DV4; Q96EH3; Q96EL3; Q96GC5; Q9BQ48; Q9BQC6; Q9BRJ2; Q9BYC8; Q9BYC9; Q9BYD1; Q9BYD2; Q9BYD3; Q9BZE1; Q9H0U6; Q9H2W6; Q9H4K7; Q9H9J2; Q9HD33; Q9NP92; Q9NQ50; Q9NRX2; Q9NVS2; Q9NWU5; Q9NX20; Q9NYK5; Q9NZE8; Q9P015; Q9P0J6; Q9P0M9; Q9Y3B7; Q9Y6G3;
2-244
100ZN; 74×MG;
Cryo-EM structure of late human 39S mitoribosome assembly intermediates, state 2 Heteromer
L0R8F8; O14561; O75394; P09001; P49406; Q13405; Q14197; Q16540; Q4U2R6; Q5T653; Q6P161; Q6P1L8; Q7Z2W9; Q7Z7F7; Q7Z7H8; Q86TS9; Q8IXM3; Q8N5N7; Q8N983; Q8TAE8; Q8TCC3; Q96A35; Q96DV4; Q96EH3; Q96EL3; Q96GC5; Q9BQ48; Q9BQC6; Q9BRJ2; Q9BYC8; Q9BYC9; Q9BYD1; Q9BYD2; Q9BYD3; Q9BZE1; Q9H0U6; Q9H2W6; Q9H9J2; Q9HD33; Q9NP92; Q9NQ50; Q9NRX2; Q9NVS2; Q9NWU5; Q9NX20; Q9NYK5; Q9NZE8; Q9P015; Q9P0M9; Q9Y3B7; Q9Y6G3;
2-244
100ZN; 49×MG;PNS;
Structure of the human mitoribosomal large subunit in complex with NSUN4.MTERF4.GTPBP7 and MALSU1.L… Heteromer
L0R8F8; O14561; O75394; P09001; P49406; Q13405; Q14197; Q16540; Q4U2R6; Q5T653; Q6P161; Q6P1L8; Q7Z2W9; Q7Z6M4; Q7Z7F7; Q7Z7H8; Q86TS9; Q8IXM3; Q8N5N7; Q8N983; Q8TAE8; Q8TCC3; Q96A35; Q96CB9; Q96DV4; Q96EH3; Q96EL3; Q96GC5; Q9BQ48; Q9BQC6; Q9BRJ2; Q9BT17; Q9BYC8; Q9BYC9; Q9BYD1; Q9BYD2; Q9BYD3; Q9BZE1; Q9H0U6; Q9H2W6; Q9H9J2; Q9HD33; Q9NP92; Q9NQ50; Q9NRX2; Q9NVS2; Q9NWU5; Q9NX20; Q9NYK5; Q9NZE8; Q9P015; Q9P0J6; Q9P0M9; Q9Y3B7; Q9Y6G3;
2-244
100ZN; 54×A; 44×U; 47×C;OMG; 31×G;PSU; 91×MG;PNS;SAM;GCP;
Structure of a human mitochondrial ribosome large subunit assembly intermediate in complex with MTE… Heteromer
L0R8F8; O14561; O75394; P09001; P49406; Q13405; Q14197; Q16540; Q4U2R6; Q5T653; Q6P1L8; Q7Z2W9; Q7Z6M4; Q7Z7F7; Q7Z7H8; Q86TS9; Q8IXM3; Q8N5N7; Q8N983; Q8TAE8; Q8TCC3; Q96A35; Q96CB9; Q96DV4; Q96EH3; Q96EL3; Q96GC5; Q9BQ48; Q9BQC6; Q9BRJ2; Q9BYC8; Q9BYC9; Q9BYD1; Q9BYD2; Q9BYD3; Q9BZE1; Q9H0U6; Q9H2W6; Q9H9J2; Q9HD33; Q9NP92; Q9NQ50; Q9NRX2; Q9NVS2; Q9NWU5; Q9NX20; Q9NYK5; Q9NZE8; Q9P015; Q9P0J6; Q9P0M9; Q9Y3B7; Q9Y6G3;
2-244
100ZN; 58×MG;GTP;
Cryo-EM structure of late human 39S mitoribosome assembly intermediates, state 4 Heteromer
L0R8F8; O14561; O75394; P09001; P49406; Q13405; Q14197; Q16540; Q4U2R6; Q5T653; Q6P161; Q6P1L8; Q7Z2W9; Q7Z6M4; Q7Z7F7; Q7Z7H8; Q86TS9; Q8IXM3; Q8N5N7; Q8N983; Q8TAE8; Q8TCC3; Q96A35; Q96CB9; Q96DV4; Q96EH3; Q96EL3; Q96GC5; Q9BQ48; Q9BQC6; Q9BRJ2; Q9BYC8; Q9BYC9; Q9BYD1; Q9BYD2; Q9BYD3; Q9BZE1; Q9H0U6; Q9H2W6; Q9H9J2; Q9HD33; Q9NP92; Q9NQ50; Q9NRX2; Q9NVS2; Q9NWU5; Q9NX20; Q9NYK5; Q9NZE8; Q9P015; Q9P0J6; Q9P0M9; Q9Y3B7; Q9Y6G3;
2-244
98.7776×MG;C;A;ZN;PNS;SAM;
Cryo-EM structure of the human 39S mitoribosome with Tigecycline Heteromer
A8K7J6; A8K9D2; E7ESL0; L0R8F8; O14561; O75394; P09001; P49406; Q13405; Q14197; Q16540; Q4U2R6; Q5T653; Q6P161; Q6P1L8; Q7Z2W9; Q7Z7F7; Q7Z7H8; Q8IXM3; Q8N5N7; Q8N983; Q8TAE8; Q8TCC3; Q96A35; Q96DV4; Q96EH3; Q96EL3; Q96GC5; Q9BQ48; Q9BQC6; Q9BRJ2; Q9BYC8; Q9BYC9; Q9BYD1; Q9BYD2; Q9BYD3; Q9BZE1; Q9H2W6; Q9H9J2; Q9HD33; Q9NP92; Q9NQ50; Q9NRX2; Q9NVS2; Q9NX20; Q9NYK5; Q9NZE8; Q9P015; Q9P0J6; Q9P0M9; Q9Y3B7; Q9Y6G3;
2-244
10095×MG;T1C;ZN;PNS;
Structure of the split human mitoribosomal large subunit with rescue factors mtRF-R and MTRES1 Heteromer
A8K7J6; A8K9D2; E7ESL0; L0R8F8; O14561; O75394; P09001; P49406; Q13405; Q14197; Q16540; Q4U2R6; Q5T653; Q6P161; Q6P1L8; Q7Z2W9; Q7Z7F7; Q7Z7H8; Q8IXM3; Q8N5N7; Q8N983; Q8TAE8; Q8TCC3; Q96A35; Q96DV4; Q96EH3; Q96EL3; Q96GC5; Q9BQ48; Q9BQC6; Q9BRJ2; Q9BYC8; Q9BYC9; Q9BYD1; Q9BYD2; Q9BYD3; Q9BZE1; Q9H2W6; Q9H3J6; Q9H9J2; Q9HD33; Q9NP92; Q9NQ50; Q9NRX2; Q9NVS2; Q9NX20; Q9NYK5; Q9NZE8; Q9P015; Q9P0M9; Q9P0P8; Q9Y3B7; Q9Y6G3;
2-244
10092×MG;ZN;PNS;
Structure of mature human mitochondrial ribosome large subunit in complex with GTPBP6 (PTC conforma… Heteromer
O43824; O75394; P09001; P49406; Q13405; Q14197; Q16540; Q4U2R6; Q5T653; Q6P161; Q6P1L8; Q7Z2W9; Q7Z7F7; Q7Z7H8; Q86TS9; Q8IXM3; Q8N5N7; Q8N983; Q8TAE8; Q8TCC3; Q96A35; Q96DV4; Q96EL3; Q96GC5; Q9BQ48; Q9BQC6; Q9BRJ2; Q9BYC8; Q9BYC9; Q9BYD1; Q9BYD2; Q9BYD3; Q9BZE1; Q9H0U6; Q9H2W6; Q9H9J2; Q9HD33; Q9NP92; Q9NQ50; Q9NRX2; Q9NVS2; Q9NWU5; Q9NX20; Q9NYK5; Q9NZE8; Q9P015; Q9P0J6; Q9P0M9; Q9Y3B7; Q9Y6G3;
2-244
100ZN; 89×MG;GTP;
Structure of a native assembly intermediate of the human mitochondrial ribosome with unfolded inter… Heteromer
L0R8F8; O14561; O75394; P09001; P49406; Q13405; Q14197; Q16540; Q4U2R6; Q5T653; Q6P161; Q6P1L8; Q7Z2W9; Q7Z7F7; Q7Z7H8; Q86TS9; Q8IXM3; Q8N5N7; Q8N983; Q8TAE8; Q8TCC3; Q96A35; Q96DV4; Q96EH3; Q96EL3; Q96GC5; Q9BQ48; Q9BQC6; Q9BRJ2; Q9BYC8; Q9BYC9; Q9BYD1; Q9BYD2; Q9BYD3; Q9BZE1; Q9H0U6; Q9H2W6; Q9H9J2; Q9HD33; Q9NP92; Q9NQ50; Q9NRX2; Q9NVS2; Q9NWU5; Q9NX20; Q9NYK5; Q9NZE8; Q9P015; Q9P0J6; Q9P0M9; Q9Y3B7; Q9Y6G3;
2-244
10092×MG;ZN;PNS;
Cryo-EM structure of the human 39S mitoribosomal subunit in complex with RRFmt and EF-G2mt. Heteromer
A8K7J6; A8K9D2; E7ESL0; O75394; P09001; P49406; P52815; Q13405; Q14197; Q16540; Q4U2R6; Q5T653; Q6P161; Q6P1L8; Q7Z2W9; Q7Z7F7; Q7Z7H8; Q8IXM3; Q8N5N7; Q8N983; Q8TAE8; Q8TCC3; Q969S9; Q96A35; Q96DV4; Q96E11; Q96EL3; Q96GC5; Q9BQ48; Q9BQC6; Q9BRJ2; Q9BYC8; Q9BYC9; Q9BYD1; Q9BYD2; Q9BYD3; Q9BZE1; Q9H2W6; Q9H9J2; Q9HD33; Q9NP92; Q9NQ50; Q9NRX2; Q9NVS2; Q9NX20; Q9NYK5; Q9NZE8; Q9P015; Q9P0J6; Q9P0M9; Q9Y3B7; Q9Y6G3;
2-244
98.77102×MG;ZN;GCP;
Cryo-EM structure of the human 39S mitoribosome with 10uM Tigecycline Heteromer
A8K7J6; A8K9D2; E7ESL0; O75394; P09001; P49406; Q13405; Q14197; Q16540; Q4U2R6; Q5T653; Q6P161; Q6P1L8; Q7Z2W9; Q7Z7F7; Q7Z7H8; Q8IXM3; Q8N5N7; Q8N983; Q8TAE8; Q8TCC3; Q96A35; Q96DV4; Q96EL3; Q96GC5; Q9BQ48; Q9BQC6; Q9BRJ2; Q9BYC8; Q9BYC9; Q9BYD1; Q9BYD2; Q9BYD3; Q9BZE1; Q9H2W6; Q9H9J2; Q9HD33; Q9NP92; Q9NQ50; Q9NRX2; Q9NVS2; Q9NX20; Q9NYK5; Q9NZE8; Q9P015; Q9P0J6; Q9P0M9; Q9Y3B7; Q9Y6G3;
2-244
10095×MG;T1C;ZN;
Structure of a human mitochondrial ribosome large subunit assembly intermediate in complex with GTP… Heteromer
L0R8F8; O14561; O43824; O75394; P09001; P49406; Q13405; Q14197; Q16540; Q4U2R6; Q5T653; Q6P161; Q6P1L8; Q7Z2W9; Q7Z7F7; Q7Z7H8; Q86TS9; Q8IXM3; Q8N5N7; Q8N983; Q8TAE8; Q8TCC3; Q96A35; Q96DV4; Q96EH3; Q96EL3; Q96GC5; Q9BQ48; Q9BQC6; Q9BRJ2; Q9BYC8; Q9BYC9; Q9BYD1; Q9BYD2; Q9BYD3; Q9BZE1; Q9H0U6; Q9H2W6; Q9H9J2; Q9HD33; Q9NP92; Q9NQ50; Q9NRX2; Q9NVS2; Q9NWU5; Q9NX20; Q9NYK5; Q9NZE8; Q9P015; Q9P0J6; Q9P0M9; Q9Y3B7; Q9Y6G3;
2-244
100ZN; 85×MG;GTP;
Large subunit of the human mitochondrial ribosome in complex with Virginiamycin M and Quinupristin Heteromer
A8K7J6; A8K9D2; E7ESL0; O75394; P09001; P49406; Q13405; Q14197; Q16540; Q4U2R6; Q5T653; Q6P161; Q6P1L8; Q7Z2W9; Q7Z7F7; Q7Z7H8; Q8IXM3; Q8N5N7; Q8N983; Q8TAE8; Q8TCC3; Q96A35; Q96DV4; Q96EL3; Q96GC5; Q9BQ48; Q9BQC6; Q9BRJ2; Q9BYC8; Q9BYC9; Q9BYD1; Q9BYD2; Q9BYD3; Q9BZE1; Q9H2W6; Q9H9J2; Q9HD33; Q9NP92; Q9NQ50; Q9NRX2; Q9NVS2; Q9NX20; Q9NYK5; Q9NZE8; Q9P015; Q9P0J6; Q9P0M9; Q9Y3B7; Q9Y6G3;
2-244
98.77ZN; 134×MG;G;H8T;
Structure of the large ribosomal subunit from human mitochondria Heteromer
O75394; P09001; P49406; Q13405; Q14197; Q16540; Q4U2R6; Q5T653; Q6P1L8; Q7Z2W9; Q7Z7H8; Q86TS9; Q8IXM3; Q8N5N7; Q8N983; Q8TAE8; Q8TCC3; Q96A35; Q96DV4; Q96EL3; Q96GC5; Q9BQ48; Q9BQC6; Q9BRJ2; Q9BYC8; Q9BYC9; Q9BYD1; Q9BYD2; Q9BYD3; Q9BZE1; Q9H0U6; Q9H2W6; Q9H9J2; Q9HD33; Q9NP92; Q9NQ50; Q9NRX2; Q9NVS2; Q9NWU5; Q9NX20; Q9NYK5; Q9NZE8; Q9P015; Q9P0J6; Q9P0M9; Q9Y3B7; Q9Y6G3;
2-244
98.77AMP; 66×MG;ZN;
Cryo-EM structure of late human 39S mitoribosome assembly intermediates, state 3A Heteromer
L0R8F8; O14561; O75394; P09001; P49406; Q13405; Q14197; Q16540; Q4U2R6; Q5T653; Q6P161; Q6P1L8; Q7Z2W9; Q7Z7F7; Q7Z7H8; Q86TS9; Q8IXM3; Q8N5N7; Q8N983; Q8TAE8; Q8TCC3; Q96A35; Q96DV4; Q96EH3; Q96EL3; Q96GC5; Q9BQ48; Q9BQC6; Q9BRJ2; Q9BYC8; Q9BYC9; Q9BYD1; Q9BYD2; Q9BYD3; Q9BZE1; Q9H0U6; Q9H2W6; Q9H9J2; Q9HD33; Q9NP92; Q9NQ50; Q9NRX2; Q9NVS2; Q9NWU5; Q9NX20; Q9NYK5; Q9NZE8; Q9P015; Q9P0M9; Q9Y3B7; Q9Y6G3;
2-244
10049×MG;ZN;PNS;
Cryo-EM structure of late human 39S mitoribosome assembly intermediates, state 5A Heteromer
L0R8F8; O14561; O75394; P09001; P49406; Q13405; Q14197; Q16540; Q4U2R6; Q5T653; Q6P161; Q6P1L8; Q7Z2W9; Q7Z7F7; Q7Z7H8; Q86TS9; Q8IXM3; Q8N5N7; Q8N983; Q8TAE8; Q8TCC3; Q96A35; Q96DV4; Q96EH3; Q96EL3; Q96GC5; Q9BQ48; Q9BQC6; Q9BRJ2; Q9BYC8; Q9BYC9; Q9BYD1; Q9BYD2; Q9BYD3; Q9BZE1; Q9H0U6; Q9H2W6; Q9H9J2; Q9HD33; Q9NP92; Q9NQ50; Q9NRX2; Q9NVS2; Q9NWU5; Q9NX20; Q9NYK5; Q9NZE8; Q9P015; Q9P0J6; Q9P0M9; Q9Y3B7; Q9Y6G3;
2-244
100ZN;MG;PNS;
mt-LSU assembly intermediate in GTPBP8 knock-out cells, state 2 Heteromer
L0R8F8; O14561; O75394; P09001; P49406; Q13405; Q14197; Q16540; Q4U2R6; Q5T653; Q6P161; Q6P1L8; Q7Z2W9; Q7Z7F7; Q7Z7H8; Q86TS9; Q8IXM3; Q8N5N7; Q8N983; Q8TAE8; Q8TCC3; Q96A35; Q96DV4; Q96EH3; Q96EL3; Q96GC5; Q9BQ48; Q9BQC6; Q9BRJ2; Q9BYC8; Q9BYC9; Q9BYD1; Q9BYD2; Q9BYD3; Q9BZE1; Q9H0U6; Q9H2W6; Q9H9J2; Q9HD33; Q9NP92; Q9NQ50; Q9NRX2; Q9NVS2; Q9NWU5; Q9NX20; Q9NYK5; Q9NZE8; Q9P015; Q9P0M9; Q9Y3B7; Q9Y6G3;
2-244
100ZN; 48×MG;PNS;
Cryo-EM structure of late human 39S mitoribosome assembly intermediates, state 3B Heteromer
L0R8F8; O14561; O75394; P09001; P49406; Q13405; Q14197; Q16540; Q4U2R6; Q5T653; Q6P161; Q6P1L8; Q7Z2W9; Q7Z7F7; Q7Z7H8; Q86TS9; Q8IXM3; Q8N5N7; Q8N983; Q8TAE8; Q8TCC3; Q96A35; Q96DV4; Q96EH3; Q96EL3; Q96GC5; Q9BQ48; Q9BQC6; Q9BRJ2; Q9BYC8; Q9BYC9; Q9BYD1; Q9BYD2; Q9BYD3; Q9BZE1; Q9H0U6; Q9H2W6; Q9H9J2; Q9HD33; Q9NP92; Q9NQ50; Q9NRX2; Q9NVS2; Q9NWU5; Q9NX20; Q9NYK5; Q9NZE8; Q9P015; Q9P0M9; Q9Y3B7; Q9Y6G3;
2-244
10049×MG;ZN;PNS;
Cryo-EM structure of late human 39S mitoribosome assembly intermediates, state 5B Heteromer
L0R8F8; O14561; O75394; P09001; P49406; Q13405; Q14197; Q16540; Q4U2R6; Q5T653; Q6P161; Q6P1L8; Q7Z2W9; Q7Z7F7; Q7Z7H8; Q86TS9; Q8IXM3; Q8N5N7; Q8N983; Q8TAE8; Q8TCC3; Q96A35; Q96DV4; Q96EH3; Q96EL3; Q96GC5; Q9BQ48; Q9BQC6; Q9BRJ2; Q9BYC8; Q9BYC9; Q9BYD1; Q9BYD2; Q9BYD3; Q9BZE1; Q9H0U6; Q9H2W6; Q9H9J2; Q9HD33; Q9NP92; Q9NQ50; Q9NRX2; Q9NVS2; Q9NWU5; Q9NX20; Q9NYK5; Q9NZE8; Q9P015; Q9P0J6; Q9P0M9; Q9Y3B7; Q9Y6G3;
2-244
100ZN;MG;PNS;
mt-LSU assembly intermediate in GTPBP8 knock-out cells, state 1 Heteromer
O75394; P09001; P49406; Q16540; Q5T653; Q6P1L8; Q7Z2W9; Q7Z7H8; Q8TCC3; Q96A35; Q96DV4; Q9BQ48; Q9BYC8; Q9BYC9; Q9BYD1; Q9BYD2; Q9BYD3; Q9BZE1; Q9H0U6; Q9HD33; Q9NRX2; Q9NWU5; Q9NX20; Q9NZE8; Q9P015; Q9P0M9; Q9Y3B7;
2-244
100
Cryo-EM structure of the human 39S mitoribosome with 5uM Tigecycline Heteromer
A8K7J6; A8K9D2; E7ESL0; O75394; P09001; P49406; Q13405; Q14197; Q16540; Q4U2R6; Q5T653; Q6P161; Q6P1L8; Q7Z2W9; Q7Z7F7; Q7Z7H8; Q8IXM3; Q8N5N7; Q8N983; Q8TAE8; Q8TCC3; Q96A35; Q96DV4; Q96EL3; Q96GC5; Q9BQ48; Q9BQC6; Q9BRJ2; Q9BYC8; Q9BYC9; Q9BYD1; Q9BYD2; Q9BYD3; Q9BZE1; Q9H2W6; Q9H9J2; Q9HD33; Q9NP92; Q9NQ50; Q9NRX2; Q9NVS2; Q9NX20; Q9NYK5; Q9NZE8; Q9P015; Q9P0J6; Q9P0M9; Q9Y3B7; Q9Y6G3;
2-244
10095×MG;T1C;ZN;
Structure of CRL2APPBP2 bound with the C-degron of MRPL28 (tetramer) Heteromer
P62877; Q13617; Q15369; Q15370; Q92624;
250-256
100ZN;

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
7o9m.21.Amonomer0.872-244
100.00